Epax Norway AS - Strategy, SWOT and Corporate Finance Report
SummaryEpax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Epax Norway AS (Epax), a subsidiary of Pelagia AS, is a producer of concentrated, marine-derived omega-3 fatty acids primarily intended for use in dietary supplements and pharmaceutical formulations. The company’s products find application in pharmaceutical and nutraceutical products. It primarily provides omega-3 active pharmaceutical ingredients (APIs) and pharmaceutical intermediates that are used for curing a wide range of health problems including cardiovascular, cognitive, pre and postnatal, joint, mood and eye health disorders. Epax operates facilities in Norway and the UK. It also sells its products under Epax brand name and distributes its products through Epax sales force and through a network of local agents and distributors. Epax is headquartered in Alesund, Norway.
Scope
- Detailed information on Epax Norway AS required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Epax Norway AS in the form of a SWOT analysis
- An in-depth view of the business model of Epax Norway AS including a breakdown and examination of key business segments
- Intelligence on Epax Norway AS's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Epax Norway AS, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of Epax Norway AS and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Epax Norway AS as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Epax Norway AS's business structure, strategy and prospects.
Croda International creates, makes, and sells specialty chemicals. Co.'s sales, marketing and research activities are organized into four global market sectors: Personal Care, which focuses on ingredients for skin, hair, sun protection and color cosmetic products; Life Sciences, which comprises of three complementary businesses: Health Care, Crop Protection, and Seed Enhancement; Performance Technologies, which targets technologies in Smart Materials and Energy Technologies and continues to develop its presence in Home Care and Water Treatment; and Industrial Chemicals, which is a sector based on selling co-streams, developing niche industrial applications and undertaking toll processing.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.